• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast cancer.

作者信息

Sclafani Francesco, Giuseppe Gullo, Mezynksi Janusz, Collins Conor, Crown John

机构信息

St Vincent's University Hospital, Dublin, Ireland.

出版信息

J Clin Oncol. 2012 Sep 10;30(26):e257-9. doi: 10.1200/JCO.2011.38.8942. Epub 2012 May 29.

DOI:10.1200/JCO.2011.38.8942
PMID:22649141
Abstract
摘要

相似文献

1
Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast cancer.
J Clin Oncol. 2012 Sep 10;30(26):e257-9. doi: 10.1200/JCO.2011.38.8942. Epub 2012 May 29.
2
[Reversible posterior leukoencephalopathy syndrome associated to bevacizumab].[与贝伐单抗相关的可逆性后部白质脑病综合征]
Rev Neurol. 2010 Jul 16;51(2):117-8.
3
Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab.可逆性后部白质脑病综合征与静脉注射贝伐单抗
Clin Exp Ophthalmol. 2008 Jan-Feb;36(1):94-6. doi: 10.1111/j.1442-9071.2007.01658.x.
4
Posterior reversible encephalopathy syndrome with bevacizumab.贝伐单抗所致的后部可逆性脑病综合征
Hong Kong Med J. 2011 Feb;17(1):80-1.
5
Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.贝伐单抗引起的可逆性后部白质脑病综合征：一例报告。
Dis Colon Rectum. 2008 Sep;51(9):1425-6. doi: 10.1007/s10350-008-9282-8. Epub 2008 May 10.
6
Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer.贝伐单抗治疗转移性卵巢癌后出现的良性可逆性脑病综合征。
Med Oncol. 2014 Feb;31(2):831. doi: 10.1007/s12032-013-0831-1. Epub 2014 Jan 3.
7
Potential withdrawal of bevacizumab for the treatment of breast cancer.贝伐单抗用于治疗乳腺癌的潜在撤药情况。
BMJ. 2011 Aug 3;343:d4946. doi: 10.1136/bmj.d4946.
8
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.贝伐单抗诱发的可逆性后部白质脑病综合征及胶质母细胞瘤患者的成功再治疗
J Clin Oncol. 2011 Oct 1;29(28):e739-42. doi: 10.1200/JCO.2011.36.1865. Epub 2011 Sep 6.
9
FDA committee votes to withdraw bevacizumab for breast cancer.美国食品药品监督管理局委员会投票决定撤销贝伐单抗用于乳腺癌的治疗。
BMJ. 2011 Jul 5;343:d4244. doi: 10.1136/bmj.d4244.
10
Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.与贝伐单抗/阿霉素治疗方案相关的可逆性后部白质脑病综合征
Br J Clin Pharmacol. 2008 May;65(5):793-4. doi: 10.1111/j.1365-2125.2008.03119.x. Epub 2008 Feb 15.

引用本文的文献

1
Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma.病例报告：乐伐替尼治疗肝细胞癌后发生的后部可逆性脑病综合征
Front Pharmacol. 2025 Mar 21;16:1487009. doi: 10.3389/fphar.2025.1487009. eCollection 2025.
2
Reversible posterior leukoencephalopathy syndrome following carboplatin and paclitaxel in cervical cancer: Case report.宫颈癌患者接受卡铂和紫杉醇治疗后出现可逆性后部白质脑病综合征：病例报告
SAGE Open Med Case Rep. 2024 May 28;12:2050313X241257444. doi: 10.1177/2050313X241257444. eCollection 2024.
3
Neuro-ophthalmic complications of modern anti-cancer drugs.
现代抗癌药物的神经眼科并发症。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2269-2281. doi: 10.1007/s00417-023-06350-4. Epub 2024 Feb 12.
4
Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review.安罗替尼治疗小细胞肺癌后出现的后部可逆性脑病综合征：一例报告及文献复习
Front Pharmacol. 2023 Feb 6;14:1126235. doi: 10.3389/fphar.2023.1126235. eCollection 2023.
5
Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review.阿帕替尼诱发的可逆性后部白质脑病综合征：1例报告及文献复习
Onco Targets Ther. 2018 Jul 30;11:4407-4411. doi: 10.2147/OTT.S166605. eCollection 2018.
6
Delirium in patients with cancer: assessment, impact, mechanisms and management.癌症患者的谵妄：评估、影响、机制和管理。
Nat Rev Clin Oncol. 2015 Feb;12(2):77-92. doi: 10.1038/nrclinonc.2014.147. Epub 2014 Sep 2.
7
Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.伊立替康和氟嘧啶化疗方案后转移性结直肠癌患者发生后部“可逆性”脑病综合征的致命结局
World J Surg Oncol. 2014 Aug 20;12:264. doi: 10.1186/1477-7819-12-264.
8
Reversible posterior encephalopathy syndrome secondary to sunitinib.
Case Rep Oncol Med. 2014;2014:952624. doi: 10.1155/2014/952624. Epub 2014 May 13.
9
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.西地尼布诱发转移性直肠癌患者出现非典型可逆性后部白质脑病综合征（RPLS）。
Invest New Drugs. 2014 Oct;32(5):1036-45. doi: 10.1007/s10637-014-0113-6. Epub 2014 May 23.
10
Posterior reversible leukoencephalopathy syndrome associated with pazopanib.与帕唑帕尼相关的后部可逆性白质脑病综合征
Case Rep Oncol. 2013 Apr 6;6(1):204-8. doi: 10.1159/000350742. Print 2013 Jan.